Clinical Trial Detail

NCT ID NCT02109445
Title Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

pancreatic ductal adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel

PF-03084014

Age Groups: adult

No variant requirements are available.